Dr. Hardy received her Ph.D. in Pharmacology from Vanderbilt University in 2011 after receiving her B.S. in Chemistry from Jackson State University in Jackson, MS. During her graduate studies at Vanderbilt, she conducted research in the laboratories of Drs. Jack Roberts and Jason Morrow in the Division of Clinical Pharmacology. Her work focused on utilizing mass spectrometry to study the formation and metabolism of biologically active lipids (eicosanoids) derived from arachidonic acid. While in graduate school, she served as a teaching fellow for the Interdisciplinary Graduate Program in Biomedical Sciences, and she tutored undergraduate and high school students in biochemistry, organic chemistry, and general chemistry. In 2011, Dr. Hardy was awarded the UNCF-Merck Postdoctoral Science Research Fellowship to conduct research at the University of Washington School of Pharmacy in the Department of Medicinal Chemistry. During her postdoctoral training, she studied drug metabolism and mechanistic toxicology under the mentorship of Drs. Allan Rettie and Sidney Nelson. Her research focused on identifying the metabolic pathways involved in the formation of chemically reactive metabolites of the tyrosine kinase inhibitor lapatinib, which is associated with idiosyncratic liver toxicity. Dr. Hardy recently joined the faculty in the Department of Pharmaceutical Sciences at Lipscomb, where she is developing a research laboratory to investigate the underlying biochemical and cellular mechanisms of drug-induced liver injury. Her research interests include characterizing the role of drug metabolism and transport in the initiation of drug-induced liver injury and identifying the downstream cellular responses that occur during the pathogenesis of liver toxicity.